biosingularity
The substrate determines the ceiling — verify a biomedical claim.
Every verdict carries a receipt. Live against PubMed, Open Targets, EBI ChEMBL, and ClinicalTrials.gov — no sign-up. The local build adds a 493 GB datalake with multi-source corroboration.
DOIs are extracted offline; each is resolved against PubMed and checked for retraction, correction, and provenance. Nothing is asserted without a receipt.
Extracts the disease, drug, and gene entities and verifies each — genes against Open Targets, drugs against ChEMBL. Nothing is asserted without a receipt. (The local build uses OpenMed NER for higher recall.)
Checks the target against Open Targets — genetic association, known-drug, and literature evidence. A weak or absent association is flagged, not hidden.
Checks a drug against ChEMBL (market withdrawal, FDA black-box warning) and a trial against ClinicalTrials.gov (terminated / withdrawn / suspended early). Nothing is asserted without a receipt.